Nicotinamide Mononucleotide, abbreviated as NMN or β-NMN, is a nucleotide that is derived from Ribose and Nicotinamide, as illustrated in the following Figure No. 01.
Design Therapeutics announced that it is launching to create and develop a new class of therapies for patients with serious degenerative disorders caused by nucleotide repeat expansions.